Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT

Raynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, MD, Didier Blaise, MD, Emanuele Angelucci, Luca Castagna, Jiri Pavlu, MDMRCP,FRCPath, Gerard Socie, MDPhD, Massimo Martino, Friedrich Stoelzel, PD, MD, Gesine Bug, Yves Chalandon, MD, Benedetto Bruno, MD, Victoria Potter, MBBS, BSc, FRACP, FRCPA, Eolia Brissot, MDPhD, Bipin N. Savani, MD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2020) 136 (Supplement 1): 9.

https://doi.org/10.1182/blood-2020-140657

Published: 2020

Journal Articles

Metabolic Syndrome Is Common Following Haematopoietic Cell Transplantation (HCT) and Is Associated with Increased Cardiovascular Disease and Second Cancers: An EBMT Cross-Sectional Non-Interventional Study

Blood (2018) 132 (Supplement 1): 251.

https://doi.org/10.1182/blood-2018-99-116533

Published: 2018

Journal Articles

Post-Transplant Sorafenib Improves Overall Survival in FLT3 Mutated AML: A Report from the EBMT Acute Leukemia Working Party

Ali Bazarbachi, MD PhD, Myriam Labopin, MD, Giorgia Battipaglia, MD, Azedine Djabali, Edouard Forcade, MD, William Arcese, Gérard Socié, MDPhD, Didier Blaise, Jakob R. Passweg, MDMS, Jan J Cornelissen, MD PhD, Patrice Chevallier, MD, Johan Maertens, MD, Nicolaas Schaap, MD PhD, Khowla Hashaishi, MD, Jean Elcheikh, MD, Florent Malard, MDPhD, Jordi Esteve, MD PhD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 708.

https://doi.org/10.1182/blood-2018-99-114044

Published: 2018

Journal Articles

Long-Term Follow-up of the Randomized Controlled Study in Patients with Newly Diagnosed Severe Aplastic Anemia Treated with ATG, Cyclosporine, with or without G-CSF: On Behalf of the SAA Working Party of the EBMT

André Tichelli, MD, Regis Peffault De Latour, Jakob R. Passweg, MD PhD, Cora Knol, Gérard Socié, MDPhD, Judith Marsh, Britta Hoechsmann, MD, Hubert Schrezenmeier, MD, Andrea Bacigalupo, MD, Sujith Samarasinghe, Alicia Rovo, MD, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Dirk-Jan Eikema, Paul Bosman, Peter Bader, MD PhD, Antonio M. Risitano, MD PhD, Carlo Dufour, MD

Blood (2018) 132 (Supplement 1): 1307.

https://doi.org/10.1182/blood-2018-99-111811

Published: 2018

Journal Articles

Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT

Noga Shem-Tov, MD, Christophe Peczynski, Myriam Labopin, MD, Maija Itälä-Remes, MD PhD, Didier Blaise, Hélène Labussière-Wallet, Gérard Socié, MDPhD, Nicolaus Kröger, MD, Per Ljungman, MD PhD, Boris Afanasyev, Patrice Chevallier, MD, Johanna Tischer, Grzegorz Helbig, Pavel Jindra, MD PhD, Sebastian Giebel, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 2174.

https://doi.org/10.1182/blood-2018-99-111604

Published: 2018

Journal Articles

Potential of Plasmatic Biomarkers to Predict Acute Gvhd Severity: A Validation Study in a Prospective Cohort of 177 Patients

Marie Robin, MD PhD, Raphael Porcher, PhD, Laetitia Taurines, Bastien Oriano, Regis Peffault De Latour, MD PhD, Flore Sicre De Fontbrune, MD, David Michonneau, MD PhD, Nathalie Dhedin, MD, Christine Chomienne, MD PhD, Gérard Socié, MDPhD, Marie-Hélène Schlageter, PharmD

Blood (2017) 130 (Supplement 1): 4480.

https://doi.org/10.1182/blood.V130.Suppl_1.4480.4480

Published: 2017

Journal Articles

First Interim Analysis of the French National Observatory of Paroxysmal Nocturnal Hemoglobinuria Clones

Magali Le Garff-Tavernier, Bernard Drenou, MD, Agathe Pruvot Debliquis, Remi Letestu, Bernard Chatelain, PhD BPharm, Thomas Boyer, Jean-Philippe Vial, MD, Michael Peres, MD, Véronique Harrivel, MD, Gérard Socié, MDPhD, Regis Peffault De Latour, MD PhD, Orianne Wagner Ballon

Blood (2017) 130 (Supplement 1): 4960.

https://doi.org/10.1182/blood.V130.Suppl_1.4960.4960

Published: 2017

Journal Articles

Impact of In Vivo T-Cell Depletion in Patients with Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Registry Study from the Chronic Malignancies Working Party of the EBMT

Blood (2017) 130 (Supplement 1): 520.

https://doi.org/10.1182/blood.V130.Suppl_1.520.520

Published: 2017

Journal Articles

The Prognostic Impact of the Donor/Recipient CMV Serostatus in Patients with Different Chronic Hematological Disorders after Allogeneic Hematopoietic Stem Cell Transplantation: A Report from the Infectious Diseases Working Party of EBMT

Blood (2017) 130 (Supplement 1): 1961.

https://doi.org/10.1182/blood.V130.Suppl_1.1961.1961

Published: 2017

Journal Articles

A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX ® (Methoxsalen) for National Institutes of Health (NIH)-Graded Moderate to Severe Chronic Graft-Vs-Host Disease (cGVHD)

Madan Jagasia, MD MBBS, MS, Hildegard T. Greinix, MD, Christof Scheid, MD, Gérard Socié, MDPhD, Francis A Ayuk, Johanna Tischer, MD, Michele L. Donato, MD, Arpad Batai, MD, Thomas Chin, MD, Henri William Boodee, MD, Ghaith Mitri, MD

Blood (2017) 130 (Supplement 1): 1970.

https://doi.org/10.1182/blood.V130.Suppl_1.1970.1970

Published: 2017

Journal Articles

Role of Allogeneic Reduced Intensity Conditioning Stem Cell Transplantation (RIC-SCT) in Older Patients with Acute Myeloid Leukemia (AML): Analysis of the ALFA-1200 Study

Blood (2017) 130 (Supplement 1): 466.

https://doi.org/10.1182/blood.V130.Suppl_1.466.466

Published: 2017

Journal Articles

Outcomes of Hematopoietic Stem Cell Transplantation after Chronic Graft Versus Host Disease and Evaluation of Revised Failure Free Survival in a Retrospective Analysis from Two Referral Centers.

Simona Pagliuca, Flore Sicre De Fontbrune, MD, Antonio M Risitano, MD PhD, David Michonneau, MD PhD, Alban Villate, MD, Rudy Birsen, Camille Rouzaud, Aurelien Sutra del Galy, Nabergoj Mitja, MD, Regis Peffault De Latour, MD PhD, Gérard Socié, MDPhD, Marie Robin, MD PhD

Blood (2017) 130 (Supplement 1): 4578.

https://doi.org/10.1182/blood.V130.Suppl_1.4578.4578

Published: 2017

Journal Articles

An EBMT Analysis of Matched Sibling, Mismatched Family or Matched Unrelated Donors for Allogeneic Stem Cell Transplants in MDS

Blood (2017) 130 (Supplement 1): 4593.

https://doi.org/10.1182/blood.V130.Suppl_1.4593.4593

Published: 2017

Journal Articles

Validation of Scores Predicting Non-Relapse Mortality in Patients with Myelodysplastic Syndrome: A Study on 1276 Patients on Behalf the Chronic Malignancies Working Party of the EBMT

Blood (2017) 130 (Supplement 1): 2028.

https://doi.org/10.1182/blood.V130.Suppl_1.2028.2028

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Monosomy 7 or Deletion 7q: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)

Blood (2017) 130 (Supplement 1): 595.

https://doi.org/10.1182/blood.V130.Suppl_1.595.595

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Marina Diaz Beya, MD, Myriam Labopin, MD PhD, Johan Maertens, Alijurf Mahmoud, MD, Alois Gratwohl, MD, Dietrich W Beelen, MD PhD, Harry C. Schouten, MD, Gérard Socié, MDPhD, Antonius VMB Schattenberg, MD PhD, Rainer Schwerdtfeger, MD, Liisa Volin, Mauricette Michallet, MD PhD, Emmanuelle Polge, Mohamad Mohty, MD PhD, Jordi Esteve, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 596.

https://doi.org/10.1182/blood.V130.Suppl_1.596.596

Published: 2017

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Adult Patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in First Complete Remission (CR1): Favorable Outcome of Patients with Negative Minimal Residual Disease (MRD) Status at Transplant. a Report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT)

Blood (2017) 130 (Supplement 1): 669.

https://doi.org/10.1182/blood.V130.Suppl_1.669.669

Published: 2017

Journal Articles

Interim Analysis of Safety Outcomes during Treatment with Eculizumab: Results from the International Paroxysmal Nocturnal Hemoglobinuria Registry

Anita Hill, MBChB (Hons), PhD, Alexander Roeth, MD, Gérard Socié, MDPhD, Marie-Pierre Caby-Tosi, PharmD, PhD, Amanda Wilson, MPH, PhD, Philippe Gustovic, MD, Camille L. Bedrosian, MD, Robert A. Brodsky, MD

Blood (2017) 130 (Supplement 1): 3486.

https://doi.org/10.1182/blood.V130.Suppl_1.3486.3486

Published: 2017

Journal Articles

Comparison of Outcome after Allogeneic Stem Cell Transplantation in AML Patients in First or Second Complete Remission Following Either Fludarabin/Busulfan, Flamsa-TBI or Flamsa-Bu Conditioning

Thomas Heinicke, MD, Myriam Labopin, MD, Christoph Schmid, Didier Blaise, Arne Brecht, MD, Jean Yves Cahn, MD PhD, Yosr Hicheri, Anne Huynh, MD, Bruno Lioure, MD, Noel Milpied, Ghulam Mufti, DM, FRCP, FRCPath, Christof Scheid, MD, Gérard Socié, MDPhD, Bipin N. Savani, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 3242.

https://doi.org/10.1182/blood.V130.Suppl_1.3242.3242

Published: 2017

Journal Articles

Health-Related Quality of Life at 1 Year in the Drepagreffe Trial Comparing Chronic Transfusion to Transplantation in Children with Sickle Cell Anemia and a History of Abnormal Cerebral Velocities

Blood (2017) 130 (Supplement 1): 617.

https://doi.org/10.1182/blood.V130.Suppl_1.617.617

Published: 2017

NARROW

Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT

Metabolic Syndrome Is Common Following Haematopoietic Cell Transplantation (HCT) and Is Associated with Increased Cardiovascular Disease and Second Cancers: An EBMT Cross-Sectional Non-Interventional Study

Post-Transplant Sorafenib Improves Overall Survival in FLT3 Mutated AML: A Report from the EBMT Acute Leukemia Working Party

Long-Term Follow-up of the Randomized Controlled Study in Patients with Newly Diagnosed Severe Aplastic Anemia Treated with ATG, Cyclosporine, with or without G-CSF: On Behalf of the SAA Working Party of the EBMT

Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT

Potential of Plasmatic Biomarkers to Predict Acute Gvhd Severity: A Validation Study in a Prospective Cohort of 177 Patients

First Interim Analysis of the French National Observatory of Paroxysmal Nocturnal Hemoglobinuria Clones

Impact of In Vivo T-Cell Depletion in Patients with Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Registry Study from the Chronic Malignancies Working Party of the EBMT

The Prognostic Impact of the Donor/Recipient CMV Serostatus in Patients with Different Chronic Hematological Disorders after Allogeneic Hematopoietic Stem Cell Transplantation: A Report from the Infectious Diseases Working Party of EBMT

A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX ® (Methoxsalen) for National Institutes of Health (NIH)-Graded Moderate to Severe Chronic Graft-Vs-Host Disease (cGVHD)

Role of Allogeneic Reduced Intensity Conditioning Stem Cell Transplantation (RIC-SCT) in Older Patients with Acute Myeloid Leukemia (AML): Analysis of the ALFA-1200 Study

Outcomes of Hematopoietic Stem Cell Transplantation after Chronic Graft Versus Host Disease and Evaluation of Revised Failure Free Survival in a Retrospective Analysis from Two Referral Centers.

An EBMT Analysis of Matched Sibling, Mismatched Family or Matched Unrelated Donors for Allogeneic Stem Cell Transplants in MDS

Validation of Scores Predicting Non-Relapse Mortality in Patients with Myelodysplastic Syndrome: A Study on 1276 Patients on Behalf the Chronic Malignancies Working Party of the EBMT

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Monosomy 7 or Deletion 7q: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Interim Analysis of Safety Outcomes during Treatment with Eculizumab: Results from the International Paroxysmal Nocturnal Hemoglobinuria Registry

Comparison of Outcome after Allogeneic Stem Cell Transplantation in AML Patients in First or Second Complete Remission Following Either Fludarabin/Busulfan, Flamsa-TBI or Flamsa-Bu Conditioning

Health-Related Quality of Life at 1 Year in the Drepagreffe Trial Comparing Chronic Transfusion to Transplantation in Children with Sickle Cell Anemia and a History of Abnormal Cerebral Velocities

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only